Advanced Search

 

Study ID Status Title Patient Level Data
115-132-V Completed A Study to Compare the Bioavailability of Atovaquone and Proguanil from Combination Tablets and from Atovaquone Tablets and Proguanil Tablets given Concomitantly
115-133 Completed Report of a Randomised Study to Evaluate a Potential Pharmacokinetic Interaction between Proguanil and Atovaquone in Healthy Adult Volunteers
115134 Completed A randomised, double-blind, placebo-controlled, cross-over study to evaluate the effect of treatment with repeat dose GSK2190915 as an add-on to current therapy on the percentage of neutrophils in induced sputum in asthmatic patients with elevated sputum neutrophils Study Listed on ClinicalStudyDataRequest.com
115-134 Completed Comparative clinical trial of a combination of atovaquone and proguanil versus amodiaquine in the treatment of acute P. falciparum malaria in adults in Gabon
115-135 Completed Final Study Report for Protocol 115-135: Comparative Clinical Trial of a Combination of Atovaquone and Proguanil versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults and Children in the Philippines
115-136 Completed Comparative Clinical Trial of a Fixed Formulation of Atovaquone and Proguanil tablets (MALARONE) Versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults or Children in Peru
115148 Completed An open-label, single dose, randomized, two-period crossover study to investigate the bioavailability of a novel dosage form of dutasteride in healthy male subjects
115151 Completed A 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI) compared with the existing COPD maintenance therapy alone in subjects with Chronic Obstructive Pulmonary Disease (COPD)
115152 Completed PGx397 whole genome sequencing of lapatinib concurrent ALT/TBL elevation and extreme ALT elevation cases
115158 Completed Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects four to six years of age (209762)
115159 Completed PGx349 Exploratory pharmacogenetic analysis of lapatinib hepatotoxicity data – association analyses, genetic signal refinement, and HLA imputation analyses
115166 Completed A Randomized, double blind, parallel group, single center, adaptive phase I study to evaluate the safety, efficacy and dose responses of SB-751689 (ronacaleret; a calcium sensing receptor antagonist) for durations not to exceed 28 days, versusplacebo in healthy human volunteers.
115168 Completed PGx366 Pharmacogenetics study of sleep-related phenotypes in subjects from ropinirole clinical studies RRL100013, 101468/204, 101468/205, ROX104805, ROR104836, ROP106064, 108862, ROX107846
115170 Completed Blinded, Re-adjudication of Mortality and Major Cardiovascular Endpoints (MACE) from the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of glycaemia in Diabetes trial (RECORD)
115198 Completed A Two-Part Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses of GSK2140944 in Healthy Adult Subjects. Study Listed on ClinicalStudyDataRequest.com
115199 Completed A randomized, double-blind, placebo-controlled, four-way crossover study to evaluate and compare the pharmacodynamics and pharmacokinetics of fluticasone furoate /vilanterol in different dose combination (50/25mcg, 100/25mcg and 200/25mcg) after single and repeat dose administration from a novel dry powder device in healthy Chinese subjects Study Listed on ClinicalStudyDataRequest.com
115207 Completed A Single-Dose, Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg×5) and Lamotrigine Compressed Tablet (25mg) in Healthy Chinese Male Subjects. Study Listed on ClinicalStudyDataRequest.com
115214 Completed An open label, single-dose, fixed sequence, two treatment period study to assess the effect of haemodialysis on the pharmacokinetics of ezogabine/retigabine and the n-acetyl metabolite of ezogabine/retigabine (NAMR). Study Listed on ClinicalStudyDataRequest.com
115215 Completed An open-label, multi-centre, single arm study to evaluate the safety and efficacy of intravenous zanamivir in the treatment of hospitalized patients with confirmed influenza infection (NAI115215) Study Listed on ClinicalStudyDataRequest.com
115227 Completed A Meta-Analysis of the Cumulative Incidence of Hypertension in the first Month of Treatment with Pazopanib Across Three Renal Cell Carcinoma Studies: VEG102616, VEG105192, and VEG107769
115231 Completed Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects seven years and older (209762)
115243 Completed An Open Label, Non-Randomized, Single dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2251052 Administered as a Single Intravenous Dose to Healthy Adult Subjects
115244 Terminated A study to evaluate the relative bioavailability of five different oral formulations of GSK2251052 and the multiple-dose, safety, tolerability, and pharmacokinetics of GSK2251052 with and without food in male and female, young and elderly healthy volunteers
115246 Completed A two part randomized, double-blind, placebo controlled study to investigate the effects of topical doses of SB705498 oncapsaicin, histamine, and cowhage responses in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
115247 Completed A 12 week study to evaluate the effect of fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI) on arterial stiffness compared with Tiotropium bromide 18 mcg delivered once daily via a HandiHaler in subjects with chronic obstructive pulmonary disease (COPD). Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.